baber/WOPTO huggingface dataset:
Patent CA-2759861-A1 (CA)
Title: Method for manufacturing silicon carbide substrate and silicon carbide substrate
Inventor: NISHIGUCHI TARO
IPC: H01L29/78
Filed: 2010-09-29
Abstract: A method for manufacturing a silicon carbide substrate includes the steps of:  preparing a base substrate (10) made of silicon carbide and a SiC substrate (20) made of single-crystal silicon carbide; forming a Si film (30) made of silicon on a main surface of the base substrate (10); fabricating a stacked substrate by placing the SiC  substrate (20) on and in contact with the Si film (30); and connecting the base substrate (10) and the SiC substrate (20) to each other by heating the stacked substrate to convert, into silicon carbide, at least a region making contact with the base substrate (10) and a region making contact with the SiC substrate (20) in the Si film (30).
Patent CA-2760328-A1 (CA)
Title: Tissue removal device with high reciprocation rate
Inventor: CHIN ALBERT CHUN-CHI
IPC: A61B17/3201
Filed: 2010-04-29
Abstract: Disclosed is a tissue removal device. The device includes an outer tubular body, an inner tubular body and a cutting edge on the inner tubular body. The outer tubular body includes a window, which may be opened or closed by moving the cutting edge. The cutting edge has a hardness that exceeds the hardness of the material of the inner tube. The cutting edge may have a Rockwell C hardness of at least about 50, while the inner tube has a Rockwell C hardness of no more than about 40. The cutting edge may be formed by a milling step, and the inner tube may be formed by a drawing step. Tissue severed by the cutting edge may be removed at a rate of at least about 1.8 grams per minute through the inner tube, and the outer tubular body may have an outside diameter of no more than about 3.5 mm.
Patent CA-2761806-A1 (CA)
Inventor: VAN DER MERWE DIRK A
IPC: G01C21/16
Filed: 2010-02-16
Abstract: A system (7010) for control of a device (7012) includes at least one sensor module (7015) detecting orientation of a users body part. The at least one sensor module is in communication with a device module configured to command an associated device. The at least one sensor module detects orientation of the body part.  The at least one sensor module sends output signals related to orientation of the user's body part to the device module and the device module controls the associated device based on the signals from the at least one sensor module.
Patent CA-2762288-A1 (CA)
Inventor: TUDOR COURTNEY JAMES
IPC: F01D5/30
Filed: 2011-12-15
Abstract: A vane includes a composite airfoil having one or more outer pockets and one or more outer spars received therein respectively. The outer spars extending radially inwardly from an outer bridge of the outer vane mount outwardly supporting airfoil. The spars may be integrally formed with the bridge and adhesively bonded to the composite airfoil within the pockets with a passage extending between an airfoil base and an airfoil tip. A  metallic leading edge tip may be disposed along the leading edge of the composite airfoil.  A gas turbine engine annular fan frame incorporates the vanes in an annular row of composite outlet guide vanes extending radially between and connecting radially inner and outer rings of the fan frame.
Patent CA-2762452-A1 (CA)
Title: An apparatus and method for removing impurities from water or wastewater
Inventor: ROBERTS R LEE
IPC: B01D35/20
Filed: 2011-12-16
Abstract: A filter for removing at least some impurities (e.g. foreign matter of any nature including a solid, a liquid or a gas) from water or wastewater. A vibrator operably associated with at least a portion of the filter for imparting a vibrational force to enhance any one or more of numerous aspects of the filtration process including: (i) installation of the filter and/or various components thereof; (ii) servicing of the filter and/or components thereof; and, (iii) operation of the filter during a filtration cycle and a cleaning cycle.
Patent CA-2764665-A1 (CA)
Inventor: LEE SUNG JAMES
IPC: A61K31/137
Filed: 2010-06-10
Abstract: The invention is directed to a composition, a use of the composition and a method of treating addiction to drugs of abuse in a subject, wherein the composition comprises a cabamoyl compound, or pharmaceutically acceptable salt or ester thereof as an active ingredient, and the method comprises administering a therapeutically effective amount of a cabamoyl compound, or pharmaceutically acceptable salt or ester thereof.
Patent CA-2764776-A1 (CA)
Inventor: IWAI TAKASHI
IPC: H04J11/00
Filed: 2010-06-25
Abstract: L'invention concerne un appareil de station mobile de radiocommunication, un appareil de station de base de radiocommunication et un procédé de radiocommunication qui permettent de commuter correctement entre des modes d'émission pour un canal PUSCH et un canal PUCCH tout en évitant d'augmenter un surdébit de signalisation. Une unité de définition du mode d'émission (107) détecte une instruction donnée par une station de base, l'instruction indiquant un procédé de multiplexage pour un canal PUSCH et un canal PUCCH. Une unité de détermination de rapport d'informations de déclenchement (108) effectue une discrimination de seuil dans laquelle la valeur PHR_pucch, qui est calculée par une unité de calcul de PHR_control (106) est comparée à une valeur de seuil qui dépend du procédé de multiplexage indiqué par l'instruction donnée par la station de base. Plus spécifiquement, dans un mode d'émission TDM, des informations de déclenchement sont rapportées si la relation PHR_pucch > X1[dBm] est satisfaite. D'autre part, dans un mode d'émission FDM, les informations de déclenchement sont rapportées si la relation PHR_pucch < Y1[dBm] est satisfaite. En fonction du résultat de la discrimination de seuil, l'unité de détermination de rapport des informations de déclenchement (108) détermine si elle doit ou non rapporter les informations de déclenchement.
Patent CA-2766080-A1 (CA)
Title: Method and apparatus for automated medical supply take/store tracking
Inventor: HULL CHRISTOPHER
IPC: G06Q10/00
Filed: 2010-07-02
Abstract: A supply cabinet is fitted with an outer sensor and an inner sensor. The outer and inner sensor wirelessly sense inventory items tagged with radio frequency tags and in proximity of the sensors, A method of tracking inventory items stored in a supply cabinet includes determining, based on time sequencing of sensing by the outer and the inner sensor, if an inventor}" item was removed from the cabinet or stored into the cabinet, and updating an inventory database accordingly. An alarm is optionally triggered if an inventory item is removed by an unauthorized user.
Patent CA-2774595-A1 (CA)
Title: Superhydrophilic amphiphilic copolymers and processes for making the same
Inventor: GARDNER JOSEPH B
IPC: C08B3/12
Filed: 2010-10-04
Abstract: A superhydrophilic amphiphilic copolymer and process for making the superhydrophilic amphiphilic copolymer includes a low molecular weight polysaccharide modified with a hydrophobic reagent, such as substituted succinic anhydride. The superhydrophilic amphiphilic copolymer system generates stable foam for use in applications, such as healthcare formulations, with low irritation of the eyes and skin.
Patent CA-2774959-A1 (CA)
Inventor: BAR-OR DAVID
IPC: A61P31/04
Filed: 2001-08-02
Abstract: The invention provides a method of inhibiting the effects of platelet activating factor (PAF). For instance, a disease or condition mediated by PAF (particularly inflammation) can be treated or platelet aggregation can be inhibited. The invention also provides a method of inhibiting the production and/or release of interleukin 8 (IL-8) by cells. The effects of PAF and the production and/or release of IL-8 are inhibited according to the invention by a compound of formula (1) wherein R1 and R2 are defined in the application, or a physiologically-acceptable salt thereof. The invention also provides pharmaceutical compositions comprising these compounds.
Patent CA-2775587-A1 (CA)
Inventor: FANG WENKUI KEN
IPC: A61K31/136
Filed: 2010-09-28
Abstract: The invention provides compounds represented by the formula I, each of which compounds may have sphingosine-1-phosphate receptor agonist and or antagonist biological activity, wherein these compounds selected from the group consisting of wherein A, B, C, D, X, Y, Z and R3 are defined in the specification. Said compounds are useful for treating a disease or condition of a mammal selected from the group consisting of ocular diseases; systemic vascular barrier related diseases; allergies and other inflammatory diseases; cardiac diseases or conditions; fibrosis; pain and wounds.
Patent CA-2776007-A1 (CA)
Title: Monitoring device for mangement of insulin delivery
Inventor: ATLAS ERAN
IPC: G06F19/00
Filed: 2010-08-24
Abstract: A monitoring system and method is presented for use with diabetic treatment management. The monitoring system comprises a control unit, and a communication interface, which configured and operable to permit access to stored raw log data, which have been obtained over a certain time and being time spaced data points of glucose measurements, meals consumed and insulin delivery. The control unit comprises an unsupervised learning controller configured and operable to receive and process said raw log data, to determine an informative data piece from residual log data portion of said raw log data and select said informative data piece for retrospective analysis to calculate at least one global insulin pump setting of basal rate, correction factor (CF), carbohydrate ratio (CR) and insulin activity curve parameters.
Patent CA-2778204-A1 (CA)
Title: Method for regulating the supply of substituate in an extracorporeal blood treatment and extracorporeal blood treatment apparatus with a device for regulating the supply of substituate
Inventor: KOPPERSCHMIDT PASCAL
IPC: A61M1/34
Filed: 2010-11-16
Abstract: The invention relates to an apparatus for extracorporeal blood treatment with a device for regulating the supply of substituate. The method according to the invention and the device according to the invention are based on the fact that the regulation of the supply of substituate in the extracorporeal blood treatment takes place as a function of the rheological loading of the dialyser. In order to regulate the supply of substituate during the extracorporeal blood treatment, the rheological loading of the dialyser is determined from the transmembrane pressure on the dialyser and the flow resistance of the dialyser and the substituate rate is increased or reduced according to the loading. The selection of dialyser parameters or blood parameters is therefore no longer necessary and the distinction between pre-dilution and post-dilution is also obsolete.
Patent CA-2778583-A1 (CA)
Title: Connection device for a supply line
Inventor: REICH REINHARD
IPC: B63B27/34
Filed: 2012-05-30
Abstract: The invention relates to a connection device for a supply line with a jacket pipe and at least two inner lines arranged therein, wherein a housing with a first connection region for the jacket pipe and a second connection region for the inner lines is provided. According to the invention the first connection region comprises at least one holding element which is mounted, for the purpose of holding or releasing the jacket pipe, so that it can be radially fed thereto or returned therefrom. The second connection region is arranged axially spaced apart from the first connection region and comprises axially actuated plug connection elements for the inner lines.
Patent CA-2783023-A1 (CA)
Inventor: AMIRI FARAHANI MOHSEN
IPC: G01K11/32
Filed: 2012-07-12
Abstract: A method and apparatus comprising acquiring spectral measurements from an optical fiber sensor. The optical fiber sensor is an SBS-based sensor such as a BOTDA. The acquired measurements are of Brillouin interactions at a point along the optical fiber being excited by the lasers of the SBS-based sensor. The acquired measurements can comprise discreet measurements of the Brillouin gain spectrum ("BGS") at the point along the fiber. The discreet measurements can be plotted as data points. A BGS can be defined by three parameters: the Brillouin frequency shift ("BFS"), the bandwidth and the peak gain. A Lorentzian curve can be used to model a BGS. A BFS can be determined by estimating the central frequency of the Lorentzian curve which is used to model the BGS. A reference Lorentzian curve with a known BFS is provided. A noisy Lorentzian curve (representing a measured signal) is provided which comprises an ideal Lorentzian curve and noise in the measurements. The reference Lorentzian curve is cross correlated with the noisy Lorentzian curve to yield a third Lorentzian curve which is the product of the cross correlation. The frequency of the maximum (the central frequency) of the third Lorentzian curve is then determined and is used to estimate the central frequency of the noisy Lorentzian curve. This central frequency along with the temperature and strain coefficients of the optical fiber are used to solve for the fiber temperature or strain.
Patent CA-2784443-A1 (CA)
Inventor: TAL MICHAEL G
IPC: A61M25/095
Filed: 2010-12-13
Abstract: An intravascular catheter may include a distal end for insertion and a proximal end. The distal end for insertion may terminate with a tip. It may define at least two openings, of which one is proximal-most in the distal end. The distal tip may include a first radiopaque marker that is discretely positioned at the proximal-most opening and radiographically distinguishes the proximal-most opening from the rest of the distal end. The distal tip may also include a second radiopaque marker that marks the tip.
Patent CA-2785237-A1 (CA)
Title: Sulphated disaccharides for the treatment of neurodegenerative and/or neurovascular diseases
Inventor: VERGES MILANO JOSEP
IPC: A61K31/7016
Filed: 2010-12-22
Abstract: The present invention relates to the use of a series of sulphated disaccharides for the preparation of a medicament for the treatment or prevention of a neurodegenerative and/or neurovascular disease, of a traumatic brain injury or of a traumatic spinal cord injury. The present invention also relates to the use of said sulphated disaccharides for the preparation of a neuroprotective medicament or of an antioxidant medicament. The neurodegenerative and/or neurovascular diseases are preferably: Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and stroke.
Patent CA-2787604-A1 (CA)
Inventor: SHIPLEY ADRIAN
IPC: B60R16/02
Filed: 2012-08-23
Abstract: One aspect of the present invention provides a power distribution system (100) for an aircraft. The power distribution system (100) comprises a first wiring harness (150 connected to a power supply (120), at least one integrated switching power converter (180, 280, 380) connected to the power supply (120) through the first wiring harness (150), and at least one electrical load (170) connected to a respective output (362) of a respective integrated switching power converter (180, 280, 380) through a second wiring harness (160). By using one or more integrated switching power converters (180, 280, 380) according to various embodiments of the present invention, a reduced total weight for the wiring needed to distribute power in the aircraft can be provided.
Patent CA-2788371-A1 (CA)
Inventor: ORGILL MICHAEL ALLEN
IPC: F16K24/00
Filed: 2012-08-30
Abstract: A breather cap assembly is provided which is configured to be connected to a stand-tube used in a watering system. When the watering system is in normal operation, the breather cap assembly is configured to allow for air to flow between the outside the assembly and the stand-tube. The breather cap assembly also provides for structure which acts as a baffle to minimize the introduction of foreign material from outside the breather cap assembly into the stand-tube. When the watering system is in flushing operation, the breather cap assembly is configured to seal off the stand-tube in order to minimize the possibility of water leaving the stand-tube. The breather cap assembly further also provides for structure which acts as a baffle to collect and retain a majority of any water that does leave the stand-tube during a flushing operation.
Patent CA-2788727-A1 (CA)
Inventor: JAEB JONATHAN
IPC: F04B43/04
Filed: 2011-02-03
Abstract: A method and apparatus for the singulation of valve plates and/or assembled valves from a lead- frame are described. The method and apparatus utilizes an electric current to fuse tabs which join the valve plate and/or the assembled valve to the lead-frame. The valve comprises a first (14) and second (16) valve plate with offsetting apertures (18,20) and a flap (17) disposed and movable between the first and second plates.
Patent CA-2788846-A1 (CA)
Inventor: MAKINO MASANORI
IPC: A61M25/02
Filed: 2012-09-06
Abstract: The present disclosure relates to a fixture 11 for fixing a tubular catheter 1 to a skin of a patient. The catheter fixture 11 is provided with a plate shaped fixture main body 21, a fixing member 41 that is configured separately from the fixture main body, and a pivot connecting shaft 45. The plate shaped fixture main body 21 includes a retention part 22 where a catheter retaining groove 25 is formed, and a pair of winged pieces 23a and 23b.  The pivot connecting shaft 45 both connects the fixture main body 21 and the fixing member 41 and acts as the pivot access C1 of the fixing member 41. The fixing member 41 has a pivoting action along a horizontal plane direction of the fixture main body 21 centrally around the pivot connecting shaft 45. When doing so, the catheter retaining groove 25 is covered by the fixing member 41 thereby fixing the catheter 1.
Patent CA-2790007-A1 (CA)
Title: Fully human anti-her2 monoclonal antibody, preparation method and use thereof
Inventor: LI CHUAN
IPC: A61P35/00
Filed: 2010-04-16
Abstract: The invention provides a fully humanized anti-HER2 antibody, which has the amino acid sequence of heavy chain variable region as defined in SEQ ID NO : 6 and the amino acid sequence of light chain variable region as defined in SEQ ID NO :8. The invention also discloses the nucleotide sequence encoding the antibody, the expression vector and the host cell comprising the nucleotide sequence, and the use of the antibody for manufacturing the medicament for the treatment of tumor.
Patent CA-2790393-A1 (CA)
Inventor: MCCAFFREY NATHANIEL JOSEPH
IPC: G01N21/00
Filed: 2011-02-18
Abstract: An analytical assembly within a unified device structure for integration into an analytical system. The analytical assembly is scalable and includes a plurality of analytical devices, each of which includes a reaction cell, an optical sensor, and at least one optical element positioned in optical communication with both the reaction cell and the sensor and which delivers optical signals from the cell to the sensor. Additional elements are optionally integrated into the analytical assembly. Methods for forming and operating the analytical system are also disclosed.
Patent CA-2791619-A1 (CA)
Inventor: SANGHA JANGBIR S
IPC: A61F13/38
Filed: 2011-02-28
Abstract: Apparatus and methods are provided for evidence specimen collection having integral reagent holders to hold reagent vials and having drying agent or desiccant holding areas that permit the renewal of the desiccant and permit the introduction of variously size desiccant qualities to allow modulation of the specimen drying time to achieve early stabilization of specimens while holding the specimen in an isolated drying area during storage and shipment and for simultaneous collection of multiple evidence samples with simultaneous storage, drying, marking, evidence security and shipping provided and with the provision for simultaneous storage, drying, marking, evidence security and shipping provided for a control specimen.
Patent CA-2795049-A1 (CA)
Inventor: KAMEN DEAN
IPC: A61M5/172
Filed: 2011-03-30
Abstract: A system for priming an infusion pump is disclosed. The system includes a priming cap including a septum and configured, to matably connect with, a male part comprising a needle and attached to a length of tubing for fluid, wherein when matably connected with the male part, the priming cap occludes the tubing.
Patent CA-2796016-A1 (CA)
Inventor: SAUGNAC FREDERIC
IPC: G06F9/445
Filed: 2011-04-26
Abstract: This method of upgrading relates to an aircraft comprising a network of computers on board the aircraft, software being loaded onto computers of the network of computers on board the aircraft. This method comprises the following steps: - interrogation of the computers of the network of computers on board the aircraft so as to ascertain the configuration of said software loaded into the computers of the network of computers on board the aircraft, - analysis by at least one computer of said configuration, - identification of the software for which there exists a more recent version than the version loaded onto the network of computers on board the aircraft, - calculation by a computer on the ground of a new software configuration for the aircraft, - construction of a set of software, incorporating updated software and corresponding to a more recent version of an item of software loaded into the computers of the network of computers on board the aircraft, - loading onto the network of computers on board the aircraft of said new configuration.
Patent CA-2796156-A1 (CA)
Inventor: SEITZ THOMAS
IPC: C07D495/04
Filed: 2011-04-11
Abstract: The invention relates to novel thienodithiin derivatives, to methods for producing same, to the use thereof for controlling undesirable microorganisms, in particular phytopathogenic fungi, in crop protection, in the area of household and hygiene and in material protection, and to crop protection agents containing said thienodithiin derivatives.
Patent CA-2797039-A1 (CA)
Title: Capsule for an extraction material, method for producing the capsule, and device for brewing coffee
Inventor: DEUBER LOUIS
IPC: B65D85/804
Filed: 2011-05-02
Abstract: According to one aspect of the invention, a coffee capsule (1) is provided, the outer dimensions of which are matched to the size of a filtered-coffee capsule, but which has a separating element (22) that separates an empty area (32) from an extraction-material area (31). Furthermore, at least one liquid channel (33) is provided, which passes through the empty area for example. The liquid channel or liquid channels and the extraction-material area are designed in such a way that water introduced into the capsule at an injection location or a beverage produced in the capsule substantially does not enter the empty area.
Patent CA-2799978-A1 (CA)
Inventor: PAWLIK ANDREAS
IPC: C08L77/00
Filed: 2012-12-27
Abstract: A process for producing a moulding with cumulative condensation of a polyamide moulding composition, comprising the following steps: a)    a polyamide moulding composition is provided, at least 50% of end groups of the polyamide taking the form of amino groups, b)    a mixture of the polyamide moulding composition and 0.1 to 5% by weight, based on the polyamide moulding composition, of an oligo- or polycarbodiimide is produced, there being essentially no cumulative condensation here, c) the mixture is optionally stored and/or transported and d)    the mixture is subsequently processed to give the moulding, the cumulative condensation not being effected until this step enables the produced of hydrolysis-resistant mouldings with geometries having large dimensions.
Patent CA-2801045-A1 (CA)
Inventor: KRISHNAMOORTHY SRINIVASAN
IPC: F03B13/00
Filed: 2013-01-02
Abstract: A novel method for producing hydropower from sea (ocean) . This method comprises a turbine-generator to produce electricity and a hydraulic press system to discharge the water to the water tank above the ground.